April 26th, 2022 – How Cellares aims to transform cell therapy manufacturing
April 26, 2022
Drug Discovery & Development
Related News
-
December 01, 2025Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO
-
September 22, 2025
Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors
-
September 17, 2025
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q’s Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control
